David J Katzoff's Net Worth
$151 Thousand
Who is David J Katzoff?
David J Katzoff does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ault Disruptive Technologies Corp, IMPERALIS HOLDING CORP., and Alzamend Neuro, Inc..
SEC CIK
David J Katzoff's CIK is 0001864317
Past Insider Trading and Trends
2023 was David J Katzoff's most active year for acquiring shares with 3 total transactions. David J Katzoff's most active month to acquire stocks was the month of May. 2022 saw David J Katzoff paying a total of $11,092.00 for 10,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ault Disruptive Technologies Corp (ADRT) Snapshot price: $12.47
Vice President - Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPERALIS HOLDING CORP. (IMHC) Snapshot price: $0.011
CFO, Secretary, TreasurerDavid J Katzoff owns 13,320 units of Common Stock which is worth $146.52. From 2021 to 2023 David J Katzoff acquired a total of 13,320 shares in IMPERALIS HOLDING CORP..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 13.32K |
—
|
—
| 13.32K |
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alzamend Neuro, Inc. (ALZN) Snapshot price: $2.12
Chief Financial OfficerDavid J Katzoff owns 81,000 units of Common Stock which is worth $171,720.00. From 2021 to 2023 David J Katzoff acquired a total of 63,000 shares in Alzamend Neuro, Inc. at a cost of $21,326.30.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +189.29% | 53K |
$0.19 | $10,234.30 | 81K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +55.56% | 10K |
$1.11 | $11,092.00 | 28K |
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||